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ARTICLE

Viral infection modulates Qa-1b in infected and
bystander cells to properly direct NK cell killing
Maria Ferez1, Cory J. Knudson1, Avital Lev2, Eric B. Wong1, Pedro Alves-Peixoto1,3,4, Lingjuan Tang1, Colby Stotesbury1, and
Luis J. Sigal1

Introduction
Natural killer (NK) cells are innate lymphocytes that become
activated early during viral infections and can protect from viral
disease by containing virus replication and spread before the
adaptive immune response develops (Diefenbach and Raulet,
2001). Similar to adaptive CTLs, a major mechanism of NK
cell’s antiviral protection is the killing of infected cells. This
process requires direct interaction of the CTL or NK cell with the
target cell and most commonly involves the exocytosis of cytolytic granules carrying the membrane pore-forming protein
perforin and pro-apoptotic enzymes such as granzyme B, which
enters the target cell cytosol (Fehniger et al., 2007; Sun and
Lanier, 2011). To avoid immunopathology due to indiscriminate killing of uninfected cells, the activation and ability of CTL
and NK cells to distinguish between infected and uninfected
cells must be tightly controlled. In CTL, this is mainly achieved
through the specific recognition of viral peptides bound to MHC
molecules by means of the antigen-specific TCR. Because NK
cells lack an antigen-specific receptor, they instead rely on the
signaling balance of relatively large numbers of inhibitory and
activating receptors that respectively prevent or promote the

killing of target cells (Diefenbach and Raulet, 2001; Lanier, 1998;
Sun and Lanier, 2011). To mount a protective NK cell response,
the activating receptor signals need to overcome the inhibitory
signals. The expression of specific inhibitory and activating receptors varies between the NK cells of an individual, creating an
NK cell repertoire. An important group of NK cell receptors are
encoded within a locus called the NK complex (NKC), which is
located in chromosome 12 in humans and 6 in mice. These receptors are specific for MHC class I (MHC-I) or MHC-I–like
molecules, including the human killer-cell Ig-like receptors,
the rodent Ly49 receptors, and the human or rodent C-type
lectins NKG2D and CD94-NKG2 (A, C, E; Long, 1999; Yokoyama
and Seaman, 1993).
CD94, NKG2A, NKG2C, and NKG2E are conserved between
humans and mice and are respectively encoded by Klrd1, Klrc1,
Klrc2, and Klrc3. CD94 alternatively forms a heterodimeric inhibitory receptor with NKG2A or activating receptors with
NKG2C and NKG2E (Lanier, 1998). CD94-NKG2 heterodimers
are generally believed to be expressed in ∼50% of NK cells, with
the vast majority of them being CD94-NKG2A, at least under
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Natural killer (NK) cell activation depends on the signaling balance of activating and inhibitory receptors. CD94 forms
inhibitory receptors with NKG2A and activating receptors with NKG2E or NKG2C. We previously demonstrated that CD94-NKG2
on NK cells and its ligand Qa-1b are important for the resistance of C57BL/6 mice to lethal ectromelia virus (ECTV) infection.
We now show that NKG2C or NKG2E deficiency does not increase susceptibility to lethal ECTV infection, but overexpression of
Qa-1b in infected cells does. We also demonstrate that Qa-1b is down-regulated in infected and up-regulated in bystander
inflammatory monocytes and B cells. Moreover, NK cells activated by ECTV infection kill Qa-1b–deficient cells in vitro and
in vivo. Thus, during viral infection, recognition of Qa-1b by activating CD94/NKG2 receptors is not critical. Instead, the levels
of Qa-1b expression are down-regulated in infected cells but increased in some bystander immune cells to respectively promote
or inhibit their killing by activated NK cells.
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background. We found that they mostly survived ECTV challenge without signs of disease, despite the fact that activating
NKG2C is commonly expressed by ∼50% of NK cells. Therefore,
in contrast to CD94, activating CD94-NKG2 receptors are not
essential to survive mousepox. We also found that recombinant
ECTV expressing Qa-1b is more pathogenic than WT ECTV in B6
mice, indicating that Qa-1b in infected cells is detrimental for
virus control. Moreover, we found that infection of mice with
WT ECTV causes Qa-1b down-regulation in infected and upregulation in uninfected bystander monocytes (MOs) and
B cells. Finally, we discovered that Qa-1b expression protects
noninfected cells in vitro and in vivo from killing by NK cells
activated by ECTV infection. Together, these results indicate
that CD94, possibly paired to NKG2A, may restrain NK cell–
mediated killing of uninfected bystander cells and that Qa-1b
down-regulation in infected cells identifies them as killing targets. Thus, Qa-1b is a switch that allows activated NK cells to
distinguish friend from foe, likely using CD94-NKG2A inhibitory
receptors.

Results
Mice deficient in NKG2E or NKG2C are resistant to
lethal mousepox
It is commonly thought that CD94/NKG2s are expressed in ∼50%
of NK cells and the majority correspond to CD94/NKG2A. This
view results from the finding that NKG2A mRNA represents 95%
of the total NKG2 mRNA in NK cells (Vance et al., 1999) as well as
from costaining of NK cells with mAbs A1611 to B6 NKG2A and
20d5 to all NKG2s (Vance et al., 2002). Also, based on costaining
of NK cells from B6 and NKG2A-deficient mice (Klrc1−/−) with
anti-NKG2s and anti-CD94 (18d3), it was concluded that NKG2C
and NKG2E are not expressed in NK cells (Rapaport et al., 2015).
Plotting NK1.1+ cells (Fig. 1 A) for expression of NKG2A (16a11)
and CD94 (18d3) shows high correlation in the upper right gate
(Fig. 1 B, dot plot). Yet, when comparing the staining of CD94
with its isotype control, it becomes apparent that most NKG2A−
cells, traditionally also considered CD94−, express CD94 but at
low levels (CD94low; Fig. 1 B, top histogram), a fact that has been
noted before (Rapaport et al., 2015). Rabbit IgG mAb (2098A)
anti-NKG2C is nonreactive with NKG2A. Accordingly, Ba/F3
cells transfected with CD94 and NKG2C stained with 2098A
(unlabeled 2098A followed by donkey anti-rabbit polyclonal IgG
labeled with Alexa 647). As expected, they also stained with
anti–NKG2A/C/E (20D5) but not with anti-NKG2A (16a11). Yet,
2098A also stained Ba/F3 cells transfected with CD94 and
NKG2E, indicating it is anti–NKG2C/E (Fig. 1 C). When we analyzed the NK cells in the spleen of B6 mice, we found that the
vast majority (if not all) of the NKG2A− NK cells were NKG2C/E+
and that ∼1/3 of the NKG2A+ NK cells were also NKG2C/E+
(Fig. 1 D). Thus, contrary to the prevalent view (Rapaport et al.,
2015; Vance et al., 2002; Vance et al., 1999), activating
CD94/NKG2s are expressed in ∼50% of NK cells under basal
conditions.
As mentioned above, previous results led us to hypothesize
that activating CD94-NKG2E on NK cells was important for resistance to ECTV (Fang et al., 2011). To test this directly, we used
Journal of Experimental Medicine
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steady-state conditions (Vance et al., 1999; Vance et al., 1998;
Vance et al., 1997). CD94-NKG2 heterodimers are also expressed
in activated T cells (Rapaport et al., 2015).
The ligands for CD94-NKG2 heterodimers are the nonclassical MHC-I molecule Qa-1b in mice (Vance et al., 1998; Zeng et al.,
2012) and HLA-E in humans (Braud et al., 1998; Lee et al., 1998;
Sullivan et al., 2007). Upon binding Qa-1b, CD94-NKG2A transmits intracellular inhibitory signals by recruiting the protein
tyrosine phosphatases SHP1 and SHP2 (Kabat et al., 2002; Le
Dréan et al., 1998). On the other hand, the activating receptors (CD94-NKG2C/E) transmit activating signals through
the transmembrane adaptor DAP10 or DAP12. In humans, NKG2C
and NKG2E directly bind DAP10/12 (Call et al., 2010), while
CD94 is the molecule responsible for binding DAP10/12 in mice
(Saether et al., 2011).
Mousepox is a deadly murine disease caused by ectromelia
virus (ECTV), an orthopoxvirus homologue to the human
pathogen variola virus, the causative agent of smallpox. ECTV
infects all mice, but the outcome of infection differs depending
on the mouse strain. While some strains such as BALB/c, DBA/2,
and A/J are susceptible, developing classic pox lesions on the
skin and succumbing to the infection within the first 7–14 d
postinfection (dpi), other strains such as C57BL/6 (B6) and 129
resist the infection without overt signs of disease (Wallace and
Buller, 1985). While multiple immune mechanisms are implicated in this resistance (Sigal, 2016), early studies showed that a
gene called Resistance to Mousepox 1 (Rmp1) mapped to the NKC,
suggesting a role for NK cells in ECTV control (Brownstein et al.,
1991). Later work demonstrated that depletion of NK cells or NK
cell deficiencies, such as in aged mice, result in susceptibility to
lethal mousepox, highlighting the important role of NK cells in
the control of ECTV (Delano and Brownstein, 1995; Fang et al.,
2008; Fang et al., 2010; Jacoby et al., 1989; Parker et al., 2007).
In previous work, we demonstrated that CD94 deficiency
renders B6 mice highly susceptible to lethal mousepox. The inability of CD94-deficient (Klrd1−/−) mice to control ECTV was due
to impaired NK cell function because its effects on virus control
occurred early, before the T cell response developed. Also, CD8
T cells from CD94-deficient mice mounted normal responses
when transferred into WT mice (Fang et al., 2011). Reporter
assays provided indirect evidence that activating CD94-NKG2E
synergized with NKG2D (an activating receptor that does not
pair with CD94) to achieve optimal NK cell activation during
ECTV infection (Fang et al., 2011). However, testing this hypothesis directly was not possible because there were no detection antibodies or genetically modified mice lacking activating
NKG2E or NKG2C. Later work in the Colonna laboratory demonstrated that male, but not female, mice deficient in NKG2A
(klrd1−/−) succumbed to mousepox. Their work also suggested
impaired CD8 T cell control due to antigen-induced cell death in
the absence of CD94-NKG2A inhibitory signals (Rapaport et al.,
2015). Yet, based on results suggesting that activating NKG2s
were not expressed by NK cells, these authors did not analyze
possible NK cell dysfunctions.
Herein, we continued to study how CD94-NKG2s contribute
to NK cell protection from mousepox. First, we generated
NKG2E (Klrc3−/−)– and NKG2C (Klrc2−/−)–deficient mice in a B6
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traditional embryo stem (ES) cell blastocyst microinjection
technology to make NKG2E-deficient mice (Klrc3−/−), where
positions 1214–4792 (3,578 bp) of the 7,249-bp Klrc3 gene (NCBI
Reference Sequence NC_000072.7, Mus musculus strain C57BL/6J
chromosome 6, GRCm39, accession no. NC_000072 REGION:
complement [129613226..129620474]) comprising exons 3–5 and
part of their flanking sequences was replaced by an irrelevant
218-bp fragment containing residual flippase recognition target
(FRT) and LoxP1 sequences (Fig. S1 A). PCR analysis of tail DNA
with forward primer positions 1092-1119 (F 1092-1119) and reverse primer positions 5018-5045 (R 5018-5045), which flank
the deleted 1214–4792 area of the WT allele, demonstrated an
expected mutant amplicon of 592 bp in Klrc3−/− but not in WT B6
mice (a possible 3,953-bp WT amplicon was not resolved by the
PCR conditions used). Conversely, PCR using forward primer
positions 4753-4779 (F 4753-4799), which is within the deleted
1214–4792 area in Klrc3−/− mice, and R 5018-5045 showed an
expected 293-bp WT amplicon in WT but not in Klrc3−/− mice
(Fig. 1 E and Fig. S1 A). Sanger sequencing of the 592-mutant
band demonstrated the expected sequence composition comprising 59 and 39 flanking areas of exons 3 and 5, respectively,
and the 218-bp insert with the FRT and LoxP sequences (Fig. S1
B). Analysis of Klrc3−/− mice splenocytes showed normal frequencies of NKG2D+, NKG2A+, and Ly49H+ NK cells (Fig. 1 F),
which are encoded in the NKC and closely linked to Klrc3
(Fig. 1 G). They also stained with anti-CD94 and anti–NKG2C/E
similarly to B6 mice (Fig. 1 H), suggesting that NKG2C but not
NKG2E is normally expressed in NK cells. Staining for additional
NK cell receptors and maturation markers suggested normal NK
cell development and phenotype (Fig. S1 C), which was consistent with the normal NK cell development previously observed
in CD94-deficient (Klrd1−/−) mice (Orr et al., 2010). When challenged with ECTV, a small percentage of Klrc3−/− mice succumbed by 10–11 dpi and all B6 mice survived, but the difference
was not statistically significant. In comparison, all klrd1−/− mice
Ferez et al.
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died from mousepox before 9 dpi, and the difference with
Klrc3−/− and B6 mice was highly significant (Fig. 1 I). Also, while a
fraction of Klrc3−/− mice had higher virus titers in their spleens,
the overall titers did not differ significantly with those of B6
mice and were significantly lower than in klrd1−/− mice (Fig. 1 J).
Thus, in contrast to CD94, NKG2E is not essential for resistance
to lethal mousepox.
Given the negative result with NKG2E, we decided to test
whether NKG2C was important for resistance to mousepox.
With this purpose, we targeted the Klrc2 gene using the improved genome editing via oviductal nucleic acids delivery
(i-GONAD) method of CRISPR/Cas9 gene editing (Gurumurthy
et al., 2019; Ohtsuka et al., 2018). A founder mouse had a GA
insertion after position 438 of transcript NCBI Reference Sequence NM_010653.4. This resulted in an early termination
codon 40 bp downstream of the insertion (Fig. S1 D). The
progeny of this mouse was bred to homozygosity to obtain
Klrc2-deficient (Klrc2−/−) mice. PCR analysis of tail DNA showed
that amplification with a forward primer specific for mutant
Klrc2 (F-Mut-Klrc2) containing the GA insertion and a common
reverse primer specific for both WT and mutant Klrc2 (R-ComKlrc2) amplified a 438-bp band in Klrc2−/− but not in WT mice,
while amplification with a forward primer specific for WT Klrc2
(F-WT-Klrc2) and R-Com-Klrc2 amplified a band of 439 bp in WT
but not in Klrc2−/− mice (Fig. 1 K). NK cells in Klrc2−/− mice
stained normally with anti-NKG2A but did not stain with anti–
NKG2C/E (Fig. 1 L, left contour plots), confirming that NKG2C is
normally expressed in the NK cells of B6 mice. Also, while the
frequency and mean fluorescence intensity (MFI) of CD94high
NK cells in Klrc2−/− mice was normal, the fluorescence intensity
of the CD94low peak was reduced to levels similar to isotype
control (Fig. 1 L, right histograms). This suggested that they did
not express CD94 due to the absence of a pairing partner. Together with the data from Klrc3−/− mice, these data suggest that
CD94-NKG2C but not CD94-NKG2E is normally present at the
Journal of Experimental Medicine
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Figure 1. Mice deficient in NKG2E or NKG2C are resistant to mousepox. (A) Representative gating strategy to identify NK cells. (B) Representative contour
plot gated on NK cells showing the expression of CD94 and NKG2A (bottom) and histogram for CD94 (filled, black line) and corresponding isotype control
(dashed line; top). (C) Representative histograms from two experiments showing staining of the indicated cell lines with the indicated antibodies (filled
histograms, black lines) or isotype control (dashed lines). (D) Representative contour plots gated on NK cells showing staining for NKG2A and NKG2C/E as
determined with mAb 2098A (left) or isotype control (right). (E) Example of PCR genotyping of Klrc3−/− and WT B6 mice using the indicated primers. (F) Graph
showing the frequency of NK cells expressing the indicated receptors in spleens from naive B6 and Klrc3−/− mice. Data are representative of two similar
experiments with three mice/group. Data were analyzed using the t test. (G) Representation of the portion of the NKC complex where NKG2 and CD94 genes
are located in mouse chromosome 6. (H) Representative contour plots (left) showing the expression of NKG2A and NKG2C/E in NK cells from B6 and Klrc3−/−
mice and histograms showing the expression of CD94 in gated NKG2A− and NKG2A+ NK cells (right) from the same mice. The dashed vertical lines intersect the
MFIs and are placed to facilitate the visual comparison of the histograms. (I) The indicated mice were infected with 3,000 pfu ECTV in the footpad, and survival
was monitored. Data are displayed as a combination of three independent experiments with a total of 10–31 mice/group. Data were analyzed using the logrank test. (J) The indicated mice were infected with ECTV, and at 7 dpi the virus loads in spleens of individual mice were determined by plaque assay. The
dotted line indicates limit of detection. Data correspond to three individual experiments combined with a total of 4–13 mice/group. Data were analyzed using
ANOVA with correction for multiple comparisons. (K) Example of PCR genotyping of Klrc2−/− and WT B6 mice using the indicated primers. (L) Contour plots
(left) showing the expression of NKG2A and NKG2C/E in NK cells from B6 and Klrc2−/− mice and histograms (right) showing the expression of CD94 or isotype
control in gated NKG2A− and NKG2A+ NK cells from the same mice. Dashed vertical lines intersect MFIs and are placed to facilitate the visual comparison of
histograms. Data correspond to a representative mouse from two experiments with three or four mice/group. (M) Graph showing the frequency of NK cells
expressing the indicated receptors in spleens from naive B6 and Klrc2−/− mice. Data are representative of two similar experiments with four mice/group. Data
were analyzed using the t test. (N) The indicated mice were infected with ECTV, and at 5 (left) or 7 (right) dpi, the virus loads, indicated as pfu, in spleens of
individual mice were determined by plaque assay. The dotted line indicates limit of detection. Data correspond to two individual experiments combined with a
total of 8–13 mice/group. Data were analyzed using the t test. (O) The indicated mice were infected with 3,000 pfu ECTV in the footpad, and survival was
monitored. Data are displayed as a combination of two independent experiments with a total of 9 or 10 mice/group. Data were analyzed using the log-rank
test. For all statistics in the figure, *, P ≤ 0.05; **, P ≤ 0.001; ****, P ≤ 0.0001. All error bars indicate mean ± SEM.
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Qa-1b interaction with CD94-NKG2 on NK cells is required for
resistance to mousepox
We previously showed that compared with B6, mice deficient in
Qa-1b (H2-T23−/−), the ligand for all CD94-NKG2 heterodimers,
had faster ECTV dissemination and were highly susceptible to
lethal mousepox (Fang et al., 2011). Thus, we investigated the
role of CD94-NKG2 interaction with Qa-1b in more detail. First,
we looked at the effect of ECTV on overall Qa-1b expression
in vivo. Compared with naive, Qa-1b was up-regulated in splenocytes at 5 dpi, which is the peak of the NK response to ECTV
(Fig. 2 A; Fang et al., 2008). When analyzed by cell type, B cells
expressed significantly more Qa-1b than other immune cells in
naive mice. At 5 dpi, B cells and MOs strongly up-regulated Qa-1b
while T cells and NK cells did minimally so (Fig. 2 B). Of note,
MOs and B cells, but not T cells or NK cells, are main targets of
ECTV infection. Also, inflammatory MOs (iMOs) have critical
roles in the protective innate immune response to ECTV in the
draining lymph node (dLN; Wong et al., 2018; Xu et al., 2015).
Next, we used the Qa-1b knock-in mouse strain H2-T23R72A,
which has a mutation in H2-T23 resulting in an R→A substitution in position 72 of Qa-1b. This substitution prevents the interaction of Qa-1b with CD94-NKG2 but does not interfere with
its interaction with the TCR (Lu et al., 2007). Qa-1b was present
and up-regulated to similar levels in B cells and MOs of WT and
H2-T23R72A mice but was absent in control H2-T23−/− mice (Fig. 2
C). Flow cytometry of splenic NK cells from H2-T23R72A stained
with Abs to various NK cell receptors and maturation markers,
indicating overall normal NK cells in these mice (Fig. S1 C).
Having found normal expression and up-regulation of Qa-1b
and normal NK cell development in H2-T23R72A mice, we determined their resistance to mousepox using B6 and H2-T23−/− mice
as controls. As previously shown (Fang et al., 2011), H2-T23−/−
mice were significantly more susceptible to lethal mousepox
than B6 mice, with almost 60% succumbing to the infection.
Notably, H2-T23R72A mice were even more susceptible, with 100%
dying before 11 dpi (Fig. 2 D). Consistent with this finding,
H2-T23R72A mice had higher virus loads than WT mice in their
spleens and livers at 3 and 7 dpi (Fig. 2 E). Because NK cells and not
T cells control the spread of ECTV from the dLN to the spleen at 3
dpi (Fang et al., 2008; Fang et al., 2011), these data indicate that the
direct interaction of Qa-1b with CD94-NKG2 on NK cells is required
for optimal control of ECTV spread and resistance to mousepox.
Ferez et al.
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Ectopic overexpression of Qa-1b in infected cells increases
susceptibility to mousepox
The data with Klrc2−/− and Klrc3−/− mice suggested that activating
signals to NK cells through CD94–NKG2C/E are not necessary for
mousepox resistance. Yet, our results above suggested that upregulation of Qa-1b in MOs and B cells and its interaction with
CD94-NKG2 on NK cells could be required for optimal resistance
to mousepox. Thus, we hypothesized that ectopic expression of
Qa-1b by ECTV would result in its attenuation in H2-T23R72A
mice. To test this, we engineered ECTV virus expressing Qa-1b
together with the red fluorescent protein dsRed (ECTV–Qa-1b–
dsRed) using methodologies previously described (Roscoe et al.,
2012). ECTV–Qa-1b–dsRed replicated to similar levels as WT
ECTV in one-step (Fig. 3 A) and multistep (Fig. 3 B) growth assays, indicating that ECTV–Qa-1b–dsRed did not have a major
direct effect on virus replication in tissue culture. Next, we
made bone marrow–derived macrophages (BMDMs) by culturing bone marrow cells for 7 d in the presence of L cell supernatant. Overnight infection of BMDMs with 5 plaque-forming
units (pfu) of ECTV–Qa-1b–dsRed resulted in increased Qa-1b
expression compared with uninfected BMDMs. Conversely, infection of BMDMs with 5 pfu WT ECTV resulted in decreased
Qa-1b expression (Fig. 3 C), suggesting that infection decreases,
rather than increases, endogenous Qa-1b expression in infected
cells. At 3 dpi, dsRed+ cells in the dLNs of ECTV–Qa-1b–dsRedinfected mice had higher fluorescence intensity for Qa-1b than in
mice infected with control ECTV-dsRed (Fig. 3 D). As expected,
B6 mice survived and H2-T23R72A succumbed to control ECTVdsRed infection. However, contrary to our expectation, not only
H2-T23R72A but also WT B6 mice succumbed to ECTV–Qa-1b–
dsRed challenge (Fig. 3 E), with increased virus titers in their
spleens at 7 dpi (Fig. 3 F). These data indicate that Qa-1b upregulation in infected cells favors rather than curtails viral
replication and disease. This strongly suggested that by imparting inhibitory signals to NK cells, Qa-1b protects infected
cells from NK cell cytolytic killing, thereby promoting virus
replication.
ECTV induces Qa-1b down-regulation in infected cells and upregulation in bystander cells in vivo
The data above showed that expression of Qa-1b is increased in
splenocytes during ECTV infection and that Qa-1b on infected
cells is detrimental for mousepox survival. This seemed to
contradict the finding that Qa-1b interaction with NK cells is
required for resistance to mousepox. A possible clue to the
problem emerged from Fig. 3 C, showing that BMDMs infected
with WT ECTV down-regulated Qa-1b. Thus, we used ECTVdsRed to determine whether the up-regulation of Qa-1b occurred in infected or uninfected iMOs and B cells in the dLN. We
found that compared with the nondraining LN, the increase in
Qa-1b expression in the dLNs at 3 dpi occurred in uninfected
(dsRed−) B cells and iMOs, and similar to BMDMs, it was significantly decreased in infected (dsRed+) iMOs (Fig. 4; this is not
possible to do in spleen because we cannot identify infected
cells by flow cytometry, likely because they are present in too
small frequency in this organ). These results suggested that
rather than promoting NK cell killing of infected cells through
Journal of Experimental Medicine
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surface of ∼50% of NK cells in WT mice and that all activating
CD94-NKG2s are absent in Klrc2−/− but not in Klrc3−/− mice. Also,
Klrc2−/− mice had normal frequencies of NKG2D+, NKG2A+, and
Ly49H+ NK cells (Fig. 1 M) and other NK cell receptors and
maturation markers (Fig. S1 C), indicating that the mutation did
not affect the expression of neighboring genes or NK cell development. When challenged with ECTV, Klrc2−/− mice had significantly increased but highly variable virus loads at 5 and 7 dpi
in their spleens compared with WT B6 mice (Fig. 1 N) but were
nonetheless fully resistant to lethal mousepox (Fig. 1 O). The data
with Klrc2−/− and Klrc3−/− mice indicate that while deficiency in
activating CD94-NKG2 heterodimers may partially affect virus
control, it is not the main reason why CD94-deficient mice are
highly susceptible to lethal mousepox.
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activating CD94–NKG2C/E, as we previously proposed, the role
of Qa-1b in resistance to mousepox could be in protecting uninfected bystander cells from detrimental killing by ECTVactivated NK cells through inhibitory CD94-NKG2A interaction.
NK cells activated by ECTV infection preferentially kill Qa-1b–
deficient uninfected targets in vitro and in vivo
To explore the possibility that Qa-1b was important to protect
bystander cells from ECTV-activated NK cell killing, NK cells
purified from spleens of mice either naive or at 5 dpi with ECTV
were added to monolayers of B6 or H2-T23−/− BMDMs. After 4 h
of coculture, BMDM viability was determined by real-time cell
analysis (RTCA) using an xCELLigence instrument (Agilent;
Fig. 5 A). The results demonstrated that NK cells obtained from
ECTV-infected mice killed B6 and H2-T23−/− BMDMs significantly better than NK cells obtained from naive mice. However,
ECTV-activated NK cells were also significantly more efficient at
Ferez et al.
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killing H2-T23−/− than B6 BMDMs (Fig. 5 B). Therefore, NK cells
activated by ECTV infection are poised to kill uninfected cells,
such as primary BMDMs, and the killing is more efficient when
the target cells do not express Qa-1b.
To test whether the preferential killing of uninfected H2T23−/− cells by ECTV-activated NK cells also occurred in vivo, we
mixed carboxyfluorescein succinimidyl ester (CFSE)–labeled
WT (CD45.1) and H2-T23−/− (CD45.2) splenocytes in a 1:1 ratio
and adoptively transferred them into naive or ECTV-infected
mice at 5 dpi. Mice were also depleted of NK cells to determine their possible role. At 18 h after transfer, the recipient
mice were euthanized, and the CFSE-labeled cells in the spleens
were identified by flow cytometry (Fig. 5 C). Results showed
that in naive mice, whether depleted of NK cells or not, the
ratios of transferred WT and H2-T23−/− cells were similar to
input ratios. On the other hand, in mice infected with ECTV,
there was preferential disappearance of H2-T23−/− cells, which
Journal of Experimental Medicine
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Figure 2. Qa-1b interaction with CD94-NKG2 on NK cells is required for optimal resistance to mousepox. (A) Flow cytometry analysis of Qa-1b expression in splenocytes from B6 mice that were naive or at 5 dpi with ECTV. Expression of Qa-1b is shown in the histogram plot. Staining with an isotype control
is shown for comparison. Data shown belong to one representative mouse/group and are representative of two experiments with 2 or 3 mice/group each.
(B) Column graphs showing the expression of Qa-1b as geometric MFI (GMFI) in the indicated cell types from B6 mice that were naive or at 5 dpi with ECTV.
Data are representative of two similar experiments with a total of 2 or 3 mice/group. Data were analyzed using ANOVA with correction for multiple comparisons. (C) Representative expression of Qa-1b in B cells and MOs from the spleens of B6, H2-T23−/−, and H2-T23R72A mice that were naive or at 5 dpi with
ECTV. Data correspond to a representative mouse per group and are representative of two experiments with 2 or 3 mice/group. (D) The indicated mice were
infected with 3,000 pfu ECTV in the footpad, and survival was monitored. Data are displayed as a combination of four independent experiments with a total of
10–31 mice/group. Data were analyzed using the log-rank test. (E) B6 and H2-T23R72A mice were infected with ECTV, and at 3 and 7 dpi the virus loads in spleens
of individual mice were determined by plaque assay. Data are displayed as a combination of two independent experiments with a total of 10–19 mice/group.
Data were analyzed using the t test. For all statistics in the figure, *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.
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was significantly abrogated by NK cell depletion (Fig. 5 D).
Therefore, NK cells activated by viral infection preferentially
killed cells that do not express Qa-1b in vivo. Similar results
were obtained in intact or NK cell–depleted mice that received a
mixture of splenocytes from WT and H2-T23R72A mice (Fig. 1 E).
Together, these data demonstrate that Qa-1b interaction with
CD94-NKG2 on NK cells protects uninfected cells from killing
by virus-activated NK cells.

Discussion
Previous work from other laboratories and ours has shown the
important role that NK cells play in resistance to mousepox
(Fang et al., 2008; Jacoby et al., 1989; Parker et al., 2007). We also
showed that the NK cell–activating receptor NKG2D contributes
to resistance to mousepox (Fang et al., 2008) and subsequently
established an essential role for CD94 and its ligand Qa-1b in the
early control of ECTV and mousepox survival (Fang et al., 2011).
The up-regulation of Qa-1b in A9 cells (America Type Culture
Collection [ATCC] CCL-1.4) infected with 1 pfu/cell ECTV in vitro
(without differentiating infected from uninfected cells) and
experiments with reporter assays suggested but did not prove
that NK cells might recognize ECTV-infected cells via activating
CD94-NKG2s in a Qa-1b–dependent manner (Fang et al., 2011).
Ferez et al.
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Yet, a more thorough study was necessary to prove this hypothesis. In this manuscript, we delved deeper to understand
how the interaction of CD94-NKG2 in NK cells and Qa-1b in
target cells contributes to mousepox resistance.
First, we created Klrc3−/− and Klrc2−/− mice and found that
they were mostly resistant to lethal mousepox. These results
indicated that the absence of activating CD94-NKG2s cannot
explain the extreme susceptibility of CD94-deficient mice. Yet,
activating CD94-NKG2 heterodimers seem to play some role in
the control of ECTV, as a few Klrc3−/− mice succumbed to the
infection and some had increased virus loads, while Klrc2−/−
mice had increased virus loads. Perhaps, we could get a better
understanding with mice deficient in both NKG2C and NKG2E.
Unfortunately, the two genes are tightly linked. Therefore,
double-deficient mice cannot be generated by crossing and
would require creating them de novo. However, it is possible
that NKG2C/NKG2E double-deficient mice will not yield
clarifying results because our data suggest that NK cells express NKG2C on the cell surface but not NKG2E. As we have
shown, CD94 is expressed in most if not all NK cells compared
with isotype control, and at least 50% stain with anti–NKG2C/
E. Yet, in Klrc2−/− mice, the staining with anti–NKG2C/E
completely disappears and the CD94low peak shifts almost to
the level of the isotype control. On the other hand, in Klrc3−/−
Journal of Experimental Medicine
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Figure 3. Ectopic expression of Qa-1b in infected cells increases susceptibility to mousepox. (A) Single-step growth of WT ECTV and ECTV–Qa-1b as
determined by infecting monolayers of BS-C-1 cells with 5 pfu/cell for the indicated times and then determining virus titers in cell lysates. (B) Multistep growth
of WT ECTV and ECTV–Qa-1b determined as in A except that the BS-C-1 cells were initially infected with 0.01 pfu/cell. (C) Qa-1b expression in BMDMs from B6
mice that were uninfected or infected overnight with 5 pfu/cell of WT-ECTV or ECTV–Qa-1b–dsRed. Data are representative of two similar experiments. The
vertical dashed line intersects the MFI of the uninfected sample and is placed to facilitate the visual comparison of the histograms. (D) Qa-1b expression as
GMFI in dsRed+ cells from the dLNs of B6 mice at 3 dpi with ECTV-dsRed or ECTV–Qa-1b–dsRed. Data are representative of two similar experiments with a
total of 6 mice/group. Data were analyzed using the t test. (E) B6 and H2-T23R72A mice were infected with 3,000 pfu of ECTV-dsRed or ECTV–Qa-1b–dsRed, and
survival was monitored. Data correspond to one experiment with 2–5 animals/group and are representative of two similar experiments. Data were analyzed
using the log-rank test. (F) B6 mice were infected with ECTV-dsRed or ECTV–Qa-1b–dsRed, and at 7 dpi the virus loads in the spleens of individual mice were
determined by plaque assay. Data correspond to two individual experiments combined with a total of 14–20 mice/group. Data were analyzed using the t test.
For all statistics in the figure, *, P ≤ 0.05; **, P ≤ 0.01. GMFI, geometric MFI.
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Figure 4. ECTV induces Qa-1b down-regulation in infected and
up-regulation in bystander MOs and B cells. Representative flow
cytometry plots for the gating of infected (dsRed+) and uninfected
(dsRed−) B cells (top) and iMOs (bottom) from the dLNs at 3 dpi with
ECTV and graphs showing the expression of Qa-1b in the indicated
cells as mean ± SEM. Data are representative of two similar experiments with a total of 8–10 mice/group. Data were analyzed using
ANOVA with correction for multiple comparisons. For all statistics in
the figure, **, P ≤ 0.01; ***, P ≤ 0.001. GMFI, geometric MFI; ndLN,
nondraining LN.
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expressing WT Qa-1b in ECTV. Contrary to our expectations, we
found that rather than being attenuated in H2-T23R72A mice,
ECTV–Qa-1b–dsRed was more pathogenic than ECTV WT in B6
mice. These results suggested that Qa-1b expression prevented
the killing of infected cells, which contradicted our previous
hypothesis that Qa-1b was elevated on infected cells, suggesting a
protective role. To clarify this discrepancy, we took advantage of
ECTV-dsRed to directly determine Qa-1b expression in infected
and noninfected iMOs and B cells in the dLNs of infected mice.
The results demonstrated that only uninfected cells upregulated Qa-1b while infected iMOs down-regulated it, hinting that Qa-1b expression may protect bystander cells from NK
cell killing. To verify the protective role of Qa-1b in uninfected
cells, we used in vitro NK cell–mediated lysis and in vivo cell
killing assay with or without NK cell depletion. In vitro, NK cells
obtained from ECTV-infected mice lysed uninfected BMDMs if
they were H2-T23−/−. Consistently, uninfected splenocytes
lacking Qa-1b or bearing the R72A Qa-1b mutation were also
preferentially killed by NK cells in mice infected with ECTV but
not in naive mice. These data indicate that bystander cells need
to express Qa-1b to avoid NK cell–mediated killing during viral
infection. Of note, we previously demonstrated that uninfected
iMOs play a major role in organizing a protective innate immune
Journal of Experimental Medicine
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mice, staining with CD94, NKG2A, and anti–NKG2C/E remains
similar to WT.
Next, we focused our attention on the CD94/NKG2 ligand,
Qa-1b. We confirmed previous results in our laboratory, showing
that H2-T23−/− mice are more susceptible to ECTV infection than
WT B6 mice (Fang et al., 2011). Notably, we also found that H2T23R72A mice, which have a mutation in Qa-1b that precludes
interaction with CD94-NKG2 (Lu et al., 2007), were fully susceptible to lethal mousepox and had significantly higher virus
loads than WT B6 mice. The reason why H2-T23R72A mice are
more susceptible to lethal mousepox than H2-T23−/− mice will
need further investigation. It is worthwhile to point out that H2T23R72A resemble Klrd1−/−, which are also 100% susceptible. On
the other hand, Klrc1−/− (Rapaport et al., 2015) as well as H2T23−/− mice are partially susceptible to ECTV infection. H2-T23−/−
and H2-T23R72A were originally made in a 129 background and
backcrossed to B6 (Hu et al., 2004; Lu et al., 2007). Therefore, it is
unlikely that genetic differences in the MHC between the two strains
account for their difference in susceptibility. Whatever the reason,
our data demonstrate that Qa-1b is capable of interacting with CD94NKG2 and is necessary for resistance to lethal mousepox.
Because lack of Qa-1b confers susceptibility to mousepox, we
attempted to rescue resistance in H2-T23R72A mice by ectopically
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Figure 5. NK cells activated by ECTV infection preferentially kill Qa-1b–deficient uninfected targets in vivo. (A) Graphical summary of the experimental
procedure for in vitro killing of BMDMs: purified NK cells obtained from either naive or ECTV-infected mice at 5 dpi were added to monolayers of B6 or H2T23−/− BMDMs. After 4 h of co-culture, BMDM viability was determined by RTCA using an xCELLigence instrument (Agilent). (B) In vitro lysis of B6 BMDMs by
the indicated NK cells. Data correspond to six individual experiments with duplicate wells. Data were analyzed using ANOVA with correction for multiple
comparisons. (C) Graphical summary of in vivo killing experimental procedure. Single-cell suspensions of lymphocyte target cells from WT CD45.1+ and H2T23−/− or H2-T23R72A naive mice were mixed in a 1:1 ratio and labeled with 4 µM CFSE, and 2 × 107 total cells were injected intravenously into recipient naive or
5-d ECTV-infected B6 mice that had been depleted or not of NK cells with anti-NK1.1 mAb PK136 (200 µg) 24 h before cell transfer. After 18 h, the mice were
killed, and the frequency of CFSE-labeled CD45.1+ (WT) and CD45.1− (H2-T23−/− or H2-T23R72A) cells was determined by flow cytometry. The differential killing
of Qa-1b–deficient cells was determined as indicated in Materials and methods. (D and E) Preferential in vivo killing of H2-T23−/− (D) or H2-T23R72A (E) cells in
the indicated mice. The control mice were injected with PBS. Data are displayed as a combination of two or three independent experiments with a total of 5–14
mice/group. Data were analyzed using ANOVA with correction for multiple comparisons. For all statistics in the figure, **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤
0.0001.
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Materials and methods
Mice
All experiments were approved by the Thomas Jefferson University Institutional Animal Care and Use Committee. WT
C57BL/6N mice (B6, B6-CD45.2) and B6.SJL-Ptprc a Pepc b /
BoyCrCrl (B6-CD45.1) mice were purchased from Charles River
or bred in-house from breeders obtained from Charles River.
CD94-deficient mice (Klrd1−/−) backcrossed to a B6 background
were previously described (Orr et al., 2010) and were bred at the
Thomas Jefferson University Animal Facility. H2-T23−/− (Hu et al.,
2004) and H2-T23R72A mice (Lu et al., 2007) in a B6 background
were a kind gift from Dr. Harvey Cantor (Dana-Farber Cancer
Institute, Boston, MA). All experiments were performed with a
mixture of male and female mice except for those with H2-T23−/−,
where only males were used because this line displays extensive
sexual dysmorphism in their response to ECTV, with most of the
females being resistant.
Klrc2−/− mice were generated in our laboratory using the
i-GONAD procedure of CRISPR/Cas9 gene editing performed as
described by others (Gurumurthy et al., 2019; Ohtsuka et al.,
2018) with a slight modification, which was the use of a Hamilton syringe instead of a mouth pipette to inject the CRISPR/
Cas9 cocktail in the oviducts of B6 females (Charles River). This
was followed by oviduct electroporation. The sequence of the
CRISPR RNA, targeting exon 3, was 59-AATCTTGGAATGACA
GTTTG-39, and the protospacer adjacent motif was GGG (Integrated DNA Technologies). The resulting Klrc2−/− mice have a GA
insertion after position 438 of the transcript NM_010653.4),
resulting in an early termination codon 40 bp downstream. For
sequencing of the mutation, primers 59-CTCTACCTGGTCACT
TTCAGCTC-39 and 59-GCGTATGGGGAACATGGGAAT-39 were
used. Mutant mice were identified by flow cytometry or by PCR
genotyping using the forward primers WT-specific F-WT-Klrc2
(59-ATCTTGGAATGACAGTTTGGG-39) or mutant-specific
F-Mut-Klrc2 (59-TCTTGGAATGACAGTGATTGG-39) together
with the reverse common primer R-Com-Klrc2 (59-ATGCAG
AGTGAAGAGACATGG-39). Conditions for PCR were 94°C for
2 min, 35 cycles of 94°C for 30 s, 66°C for 30 s, 72°C for 30 s, and
final extension at 72°C for 5 min.
Ferez et al.
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To generate Klrc3−/− mice, B6 agouti (JM8A3.N1)–targeted
Klrc3tm1(KOMP) ES cells were purchased from the Mutant Mouse
Resource and Research Center at the University of California,
Davis, a National Institutes of Health–funded strain repository.
These ES cells were originally created by Pieter de Jong, Kent
Lloyd, William Skarnes, and Allan Bradley at the Wellcome
Sanger Institute and donated to the Mutant Mouse Resource and
Research Center by The KOMP Repository at the University of
California, Davis. Klrc3tm1(KOMP) ES cells had the Klrc3 gene
(NCBI Reference Sequence NC_000072.7, Mus musculus strain
C57BL/6J chromosome 6, GRCm39, accession no. NC_000072
REGION: complement [129613226..129620474]) with positions
1214–4792 comprising exons 3–5 and part of the flanking introns
replaced by a 7,122-bp cassette containing the Neo and LacZ
genes as well as LoxP and FRT sequences for Neo or Neo and
LacZ removal by Cre or Flippase (Flp) recombinases, respectively.
Klrc3tm1(KOMP) ES cells were injected into blastocysts, which
were then transferred to surrogate mothers by the Fox Chase
Cancer Center Tissue Culture and Transgenic Mouse facilities.
Chimeric mice were identified by agouti coat color and bred to
WT B6 mice. An F1 carrier was identified by a PCR amplicon of
722 bp when using tail DNA and forward neo specific primer
(F-neo; 59-GGGATCTCATGCTGGAGTTCTTCG-39) corresponding
to positions 6653–6676 of the cassette and the reverse primer R
5018-5045 of the WT Klrc3 gene. The progeny of the founder
mouse was bred to homozygosity to produce mice deficient in
Klrc3 with an inserted Neo/LacZ cassette (Klrc3nl/nl). The definitive Klc3−/− strain was generated by crossing Klrc3nl/nl mice with
B6;SJL-Tg(ACTFLPe)9205Dym (Stock No: 003800; The Jackson
Laboratory) carrying Flp to remove most of the cassette.
Klrc3−/− mice contained positions 1214–4792 (3,578 bp) of Klrc3
replaced by a 218-bp leftover from the cassette containing
single FRT and LoxP sites. Homozygous Klrc3−/− mice were
identified by the presence of a mutant-specific PCR amplicon
of 592 bp when using tail DNA and primers F 1092–1119 of the
Klrc3 gene and R 5018-5045, as well as absence of a WT PCR
amplicon of 293 bp with primers F 4753-4779 and R 5018-5045.
The identity of the 592-bp mutant band was verified by
Sanger sequencing. Klrc3−/− mice lacking the Flp gene were
selected for further breeding.
Viruses and infection
ECTV (strain Moscow) was obtained from ATCC (#VR-1374).
ECTV-GFP and ECTV-dsRed were previously described (Fang
et al., 2008; Roscoe et al., 2012). ECTV–Qa-1b–dsRed was generated by standard homologous recombination using a virus
deficient in EVM036 as previously described (Roscoe et al.,
2012). All ECTV strains were propagated in tissue culture as
previously described (Xu et al., 2008). Mice were infected in the
left hind footpad with 3,000 pfu ECTV. For survival analysis,
mice were monitored daily, being euthanized when they showed
signs of imminent death (lack of movements and unresponsiveness to touch) and were recorded as dead. Euthanasia was
performed according to the 2013 edition of the American Veterinary Medical Association Guideline for the Euthanasia of
Animals. For virus titers, spleens or livers were homogenized in
2.5% FBS RPMI (Corning) using a TissueLyser (QIAGEN). Virus
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response in the dLN that restricts early virus spread (Wong
et al., 2018; Xu et al., 2015), and we have shown herein that
ECTV spread is accelerated in H2-T23R72A mice. This suggests
that the killing of uninfected iMOs in H2-T23R72A mice may play
an important role in the susceptibility of this strain to ECTV.
Future experiments will address this hypothesis.
In summary, our data indicate that the up-regulation of Qa-1b
in bystander cells functions as a “don’t kill me” signal for NK
cells, while its down-regulation in infected cells provides a “kill
me” signal, a variation of the missing-self hypothesis (Bern et al.,
2019; Kärre et al., 1986) where loss of Qa-1b would relieve inhibitory signals. Yet, this switch function of Qa-1b only occurs in
NK cells activated by viral infection because resting NK cells do
not preferentially kill H2-T23−/− or H2-T23R72A targets. These
results provide a previously unknown mechanism for the regulation of NK cell antiviral function.
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titers were determined on BS-C-1 cells as previously described
(Xu et al., 2008).

In vivo depletion of NK cells
Depletion of NK cells in B6 mice was performed by i.p. inoculation of 200 µg NK1.1 mAb PK136 24 h before adoptive cell
transfer as before (Fang et al., 2008).
Flow cytometry
Flow cytometry was performed as described previously (Fang
et al., 2008; Fang et al., 2011; Fang and Sigal, 2010; Xu et al.,
2008). Briefly, LNs and spleens were obtained from mice and
suspended in single-cell suspensions. Nonspecific binding of
mAbs to the Fc receptor was blocked with antibody 2.4G2
(anti–Fc-g II/III receptor; ATCC), followed by surface and/or
intracellular staining. We used the following antibodies: anti–
Qa-1(b) (clone 6A8.6F10.1A6; biotin, BD Biosciences), Streptavidin (APC, PE-Cy7), anti-CD3ε (clone 145-2C11; FITC, Pacific Blue,
PE-Cy7), anti-CD3 (clone 17A2; Brilliant Violet 785), anti-TCRβ
(clone H57-597; PB, BV 785), anti-NKp46 (clone 29A1.4; APC, PECy7), anti-NK1.1 (clone PK136; APC, BV 605, PE-Cy7), anti-CD45
(clone 30-F11; PerCP-Cy5.5), anti-CD27 (clone LG.3A10; PerCPCy5.5), anti-CD45.1 (clone A20; PB), anti-CD45.2 (clone 104; PE),
anti-CD11b (clone M1/70; BV 605, PE-Cy7), anti-CD49b (clone
DX5; APC), anti-CD94 (clone18d3; FITC, PE, eBioscience; BV 421,
BD Biosciences), anti-Ly49H (clone 3D10; FITC, PE), anti–
NKG2A/C/E (clone 20d5; FITC; eBioscience), anti-NKG2AB6
(clone 16a11; PE, eBioscience), anti-NKG2D (clone CX5; APC), antiNKG2C/E (clone 2098A; Unconjugated, R&D Systems), normal
rabbit IgG (clone 60024B; Unconjugated, R&D Systems), antirabbit donkey IgG (Poly4064; Alexa Fluor647), anti-CD69
(clone H1.2F3; FITC), anti–Ly-6C (clone HK1.4; PerCP), antiCD19 (clone 6D5; PerCP/Cy5.5), anti-CD127 (clone SB/199;
APC), anti-B220 (clone RA3-6B2; PerCP/Cy5.5), anti–KLRG-1
(clone 2F1/KLRG1; PE-Cy7), anti–Ly49C/I (clone 5E6; FITC, BD
Biosciences), anti-Ly49D (clone 4E5; PE), Ly49G2 (clone
eBio4D11; FITC, eBioscience), anti-Ly49H (clone 3D10; PE),
and anti-Eomes (clone Dan11mag; PE-Cy7, eBioscience). All
antibodies and any corresponding isotype antibodies were
purchased from Biolegend unless otherwise stated. For Eomes
staining, extracellular molecules were stained as described
Ferez et al.
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In vitro cytotoxicity assay
In vitro NK cell killing of bone marrow macrophages was determined using an xCELLigence RTCA instrument (Agilent). For
this purpose, 40,000 B6 or H2-T23−/− BMDMs (target cells) were
seeded in individual wells of e-plates (Agilent), placed in the
RTCA instrument chamber, and incubated at 37°C until the cell
index (CI) as read by the instrument reached a plateau (∼24 h).
NK cells were isolated from naive and 5-dpi B6 splenocytes using
the MojoSort Mouse NK Cell Isolation Kit (Biolegend) according
to the manufacturer’s instructions, and the purity was assessed
by flow cytometry. Purified NK cells (effector cells) were added
to each well of BMDMs in a 20:1 effector-target cell ratio. The
CI observed at 4 h following effector cell addition was used to
determine cell lysis according to the formula % lysis = CI no
effector − CI effector/CI no effector × 100.
In vivo cytotoxicity assay
Whole splenocytes were isolated from B6-CD45.1 (CD45.1+ CD45.2−)
and H2-T23−/− (CD45.1−CD45.2+) or H2-T23R72A (CD45.1−CD45.2+)
mice mixed in a 1:1 ratio, stained with 4 µM CFSE, and 2 × 107
cells were injected intravenously into recipient mice that had
been infected or not with ECTV 5 d earlier. After 18 h, mice
were euthanized, and spleens were processed into single-cell
suspensions and analyzed by flow cytometry. Preferential killing
was calculated based on the ratio of CD45.1+ and CD45.2+ frequencies of CFSE-labeled cells obtained before the injection. To
calculate specific lysis after transfer, the following formula was
used: % specific lysis = [1 − (ratio after transfer/ratio before
transfer)] × 100, where “ratio” is % CD45.2/% CD45.1. Therefore,
a positive specific lysis number indicates preferential killing of
CD45.2+ cells, whereas a negative number implies preferential
killing of CD45.1+ cells. A specific killing value of zero would
suggest no preferential killing.
Statistical analysis
Data were analyzed with Prism 6 software (GraphPad). For
survival, we used the log-rank (Mantel-Cox) test. For other experiments, ANOVA with Tukey correction for multiple comparisons or Student’s t test was used as applicable. For all
figures, *, P < 0.05, **, P < 0.01, ***, P < 0.001, ****, P < 0.0001.
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Tissue culture
For ECTV growth and titration, we used BS-C-1 cells (#CCL-26;
ATCC). Ba/F3 cells coexpressing CD94 and NKG2E (CT785) or
CD94 and NKG2C (CT750) were a gift from Dr. Lewis L. Lanier
(University of California, San Francisco, San Francisco, CA) and
have been described previously (Fang et al., 2011). BMDMs were
produced from bone marrow cells grown in supernatant of A9
cells (CCL-1.4; ATCC) as previously described (Ramirez and
Sigal, 2002). For cell culture, we used RPMI-1640 tissue culture medium (Invitrogen Life Technologies) supplemented with
10% FCS (Sigma-Aldrich), 100 IU/ml penicillin and 100 µg/ml
streptomycin (Invitrogen Life Technologies), 10 mM Hepes
buffer (Invitrogen Life Technologies), and 0.05 mM 2-ME
(Sigma-Aldrich). For virus growth and titers, RPMI with 2.5%
FCS was used. All cells were grown at 37°C with 5% CO2.

above, and cells were incubated in eBioscience intracellular
fixation and permeabilization buffer (Thermo Fisher) for
40 min at 4°C. Cells were stained with anti-Eomes antibody in
permeabilization buffer (Thermo Fisher). Cells were analyzed
at the Thomas Jefferson University Flow Cytometry Facilities
using LSR II and Fortessa instruments (Becton Dickinson).

Online supplemental material
Fig. S1 shows a diagram of the Klrc3 gene with the 3,578-bp deletion/218-bp insertion in Klrc3−/− mice and the localization of
the primers used for genotyping in Fig. 1 E; partial trace corresponding to the Sanger sequencing of the 592-bp amplicon resulting from the genotyping of Klrc3−/− mice; the phenotyping of
WT, H2-T23−/−, H2-T23R72A, Klrc3−/−, and Klrc2−/− NK cells as determined by flow cytometry using various mAbs; and partial
traces corresponding to the Sanger sequencing of the 578-bp
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amplicon resulting from the PCR amplification of exon 3 from
WT and Klrc2−/− mice using genotyping primers.
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Figure S1. Characterization of mouse lines. (A) Diagram of the Klrc3 gene showing the 3,578-bp deletion/218-bp insertion in Klrc3−/− mice and the localization of the primers used for genotyping in Fig. 1 E. (B) Partial trace corresponding to the Sanger sequencing of the 592-bp amplicon resulting from the PCR
amplification using the indicated primers with DNA from Klrc3−/− mice. The sequences of the residual FRT and LoxP sites are respectively boxed in magenta and
cyan. (C) Flow cytometry analysis of splenocytes from the indicated mice with mAbs directed to the indicated markers. Data correspond to one representative
experiment from two experiments with 3–5 mice/group in each (the experiment with R72A was performed only once with five mice due to lack of mice). Data
were analyzed using ANOVA with correction for multiple comparisons. All comparisons were not significant. Error bars indicate mean ± SEM. (D) Partial traces
corresponding to the Sanger sequencing of the 578-bp amplicon resulting from the PCR amplification of exon 3 from WT and Klrc2−/− mice using primers 59-CTC
TACCTGGTCACTTTCAGCTC-39 and 59-GCGTATGGGGAACATGGGAAT-39. The G and A insertions in the Klrc2−/− gene are marked with magenta arrows.

Ferez et al.
Qa-1b in viral infection

Journal of Experimental Medicine
https://doi.org/10.1084/jem.20201782

S2

